調査レポート | • レポートコード：QYR2104Z0378 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、抗凝固療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NOAC、ワルファリン）、用途別市場規模（院内クリニック、独立クリニック、薬局ベースクリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗凝固療法の市場動向 ・企業の競争状況、市場シェア ・抗凝固療法の種類別市場規模（NOAC、ワルファリン） ・抗凝固療法の用途別市場規模（院内クリニック、独立クリニック、薬局ベースクリニック） ・抗凝固療法の北米市場規模2016-2027（アメリカ、カナダ） ・抗凝固療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗凝固療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗凝固療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗凝固療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CH Boehringer Sohn、Bristol-Myers Squibb、Johnson＆Johnson、Pfizer、Daiichi Sankyo、Portola Pharmaceuticals、Roche、Abbott） ・結論 |
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC’s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.
Market Analysis and Insights: Global Anticoagulation Therapy Market
The global Anticoagulation Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anticoagulation Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anticoagulation Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anticoagulation Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anticoagulation Therapy market.
Global Anticoagulation Therapy Scope and Market Size
Anticoagulation Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulation Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
NOACs
Warfarin
Segment by Application
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson＆Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulation Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NOACs
1.2.3 Warfarin
1.3 Market by Application
1.3.1 Global Anticoagulation Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Associated Clinics
1.3.3 Independent Clinics
1.3.4 Pharmacy-Based Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulation Therapy Market Perspective (2016-2027)
2.2 Anticoagulation Therapy Growth Trends by Regions
2.2.1 Anticoagulation Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anticoagulation Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Anticoagulation Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Anticoagulation Therapy Industry Dynamic
2.3.1 Anticoagulation Therapy Market Trends
2.3.2 Anticoagulation Therapy Market Drivers
2.3.3 Anticoagulation Therapy Market Challenges
2.3.4 Anticoagulation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulation Therapy Players by Revenue
3.1.1 Global Top Anticoagulation Therapy Players by Revenue (2016-2021)
3.1.2 Global Anticoagulation Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Anticoagulation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anticoagulation Therapy Revenue
3.4 Global Anticoagulation Therapy Market Concentration Ratio
3.4.1 Global Anticoagulation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulation Therapy Revenue in 2020
3.5 Anticoagulation Therapy Key Players Head office and Area Served
3.6 Key Players Anticoagulation Therapy Product Solution and Service
3.7 Date of Enter into Anticoagulation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulation Therapy Breakdown Data by Type
4.1 Global Anticoagulation Therapy Historic Market Size by Type (2016-2021)
4.2 Global Anticoagulation Therapy Forecasted Market Size by Type (2022-2027)
5 Anticoagulation Therapy Breakdown Data by Application
5.1 Global Anticoagulation Therapy Historic Market Size by Application (2016-2021)
5.2 Global Anticoagulation Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anticoagulation Therapy Market Size (2016-2027)
6.2 North America Anticoagulation Therapy Market Size by Type
6.2.1 North America Anticoagulation Therapy Market Size by Type (2016-2021)
6.2.2 North America Anticoagulation Therapy Market Size by Type (2022-2027)
6.2.3 North America Anticoagulation Therapy Market Size by Type (2016-2027)
6.3 North America Anticoagulation Therapy Market Size by Application
6.3.1 North America Anticoagulation Therapy Market Size by Application (2016-2021)
6.3.2 North America Anticoagulation Therapy Market Size by Application (2022-2027)
6.3.3 North America Anticoagulation Therapy Market Size by Application (2016-2027)
6.4 North America Anticoagulation Therapy Market Size by Country
6.4.1 North America Anticoagulation Therapy Market Size by Country (2016-2021)
6.4.2 North America Anticoagulation Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anticoagulation Therapy Market Size (2016-2027)
7.2 Europe Anticoagulation Therapy Market Size by Type
7.2.1 Europe Anticoagulation Therapy Market Size by Type (2016-2021)
7.2.2 Europe Anticoagulation Therapy Market Size by Type (2022-2027)
7.2.3 Europe Anticoagulation Therapy Market Size by Type (2016-2027)
7.3 Europe Anticoagulation Therapy Market Size by Application
7.3.1 Europe Anticoagulation Therapy Market Size by Application (2016-2021)
7.3.2 Europe Anticoagulation Therapy Market Size by Application (2022-2027)
7.3.3 Europe Anticoagulation Therapy Market Size by Application (2016-2027)
7.4 Europe Anticoagulation Therapy Market Size by Country
7.4.1 Europe Anticoagulation Therapy Market Size by Country (2016-2021)
7.4.2 Europe Anticoagulation Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulation Therapy Market Size (2016-2027)
8.2 Asia-Pacific Anticoagulation Therapy Market Size by Type
8.2.1 Asia-Pacific Anticoagulation Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anticoagulation Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anticoagulation Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Anticoagulation Therapy Market Size by Application
8.3.1 Asia-Pacific Anticoagulation Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anticoagulation Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anticoagulation Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Anticoagulation Therapy Market Size by Region
8.4.1 Asia-Pacific Anticoagulation Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anticoagulation Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anticoagulation Therapy Market Size (2016-2027)
9.2 Latin America Anticoagulation Therapy Market Size by Type
9.2.1 Latin America Anticoagulation Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Anticoagulation Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Anticoagulation Therapy Market Size by Type (2016-2027)
9.3 Latin America Anticoagulation Therapy Market Size by Application
9.3.1 Latin America Anticoagulation Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Anticoagulation Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Anticoagulation Therapy Market Size by Application (2016-2027)
9.4 Latin America Anticoagulation Therapy Market Size by Country
9.4.1 Latin America Anticoagulation Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Anticoagulation Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulation Therapy Market Size (2016-2027)
10.2 Middle East & Africa Anticoagulation Therapy Market Size by Type
10.2.1 Middle East & Africa Anticoagulation Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anticoagulation Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anticoagulation Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Anticoagulation Therapy Market Size by Application
10.3.1 Middle East & Africa Anticoagulation Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anticoagulation Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anticoagulation Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Anticoagulation Therapy Market Size by Country
10.4.1 Middle East & Africa Anticoagulation Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anticoagulation Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CH Boehringer Sohn
11.1.1 CH Boehringer Sohn Company Details
11.1.2 CH Boehringer Sohn Business Overview
11.1.3 CH Boehringer Sohn Anticoagulation Therapy Introduction
11.1.4 CH Boehringer Sohn Revenue in Anticoagulation Therapy Business (2016-2021)
11.1.5 CH Boehringer Sohn Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Anticoagulation Therapy Introduction
11.2.4 Bristol-Myers Squibb Revenue in Anticoagulation Therapy Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Johnson＆Johnson
11.3.1 Johnson＆Johnson Company Details
11.3.2 Johnson＆Johnson Business Overview
11.3.3 Johnson＆Johnson Anticoagulation Therapy Introduction
11.3.4 Johnson＆Johnson Revenue in Anticoagulation Therapy Business (2016-2021)
11.3.5 Johnson＆Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Anticoagulation Therapy Introduction
11.4.4 Pfizer Revenue in Anticoagulation Therapy Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Anticoagulation Therapy Introduction
11.5.4 Daiichi Sankyo Revenue in Anticoagulation Therapy Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 Portola Pharmaceuticals
11.6.1 Portola Pharmaceuticals Company Details
11.6.2 Portola Pharmaceuticals Business Overview
11.6.3 Portola Pharmaceuticals Anticoagulation Therapy Introduction
11.6.4 Portola Pharmaceuticals Revenue in Anticoagulation Therapy Business (2016-2021)
11.6.5 Portola Pharmaceuticals Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anticoagulation Therapy Introduction
11.7.4 Roche Revenue in Anticoagulation Therapy Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Anticoagulation Therapy Introduction
11.8.4 Abbott Revenue in Anticoagulation Therapy Business (2016-2021)
11.8.5 Abbott Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anticoagulation Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NOACs
Table 3. Key Players of Warfarin
Table 4. Global Anticoagulation Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anticoagulation Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anticoagulation Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anticoagulation Therapy Market Share by Regions (2016-2021)
Table 8. Global Anticoagulation Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anticoagulation Therapy Market Share by Regions (2022-2027)
Table 10. Anticoagulation Therapy Market Trends
Table 11. Anticoagulation Therapy Market Drivers
Table 12. Anticoagulation Therapy Market Challenges
Table 13. Anticoagulation Therapy Market Restraints
Table 14. Global Anticoagulation Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anticoagulation Therapy Market Share by Players (2016-2021)
Table 16. Global Top Anticoagulation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulation Therapy as of 2020)
Table 17. Ranking of Global Top Anticoagulation Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anticoagulation Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anticoagulation Therapy Product Solution and Service
Table 21. Date of Enter into Anticoagulation Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anticoagulation Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Anticoagulation Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anticoagulation Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anticoagulation Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anticoagulation Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Anticoagulation Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anticoagulation Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anticoagulation Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anticoagulation Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anticoagulation Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anticoagulation Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anticoagulation Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anticoagulation Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anticoagulation Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anticoagulation Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anticoagulation Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anticoagulation Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anticoagulation Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anticoagulation Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anticoagulation Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anticoagulation Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anticoagulation Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anticoagulation Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anticoagulation Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anticoagulation Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anticoagulation Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anticoagulation Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anticoagulation Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anticoagulation Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anticoagulation Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anticoagulation Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anticoagulation Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anticoagulation Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. CH Boehringer Sohn Company Details
Table 62. CH Boehringer Sohn Business Overview
Table 63. CH Boehringer Sohn Anticoagulation Therapy Product
Table 64. CH Boehringer Sohn Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 65. CH Boehringer Sohn Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Anticoagulation Therapy Product
Table 69. Bristol-Myers Squibb Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Johnson＆Johnson Company Details
Table 72. Johnson＆Johnson Business Overview
Table 73. Johnson＆Johnson Anticoagulation Therapy Product
Table 74. Johnson＆Johnson Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 75. Johnson＆Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Anticoagulation Therapy Product
Table 79. Pfizer Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Daiichi Sankyo Company Details
Table 82. Daiichi Sankyo Business Overview
Table 83. Daiichi Sankyo Anticoagulation Therapy Product
Table 84. Daiichi Sankyo Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 85. Daiichi Sankyo Recent Development
Table 86. Portola Pharmaceuticals Company Details
Table 87. Portola Pharmaceuticals Business Overview
Table 88. Portola Pharmaceuticals Anticoagulation Therapy Product
Table 89. Portola Pharmaceuticals Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 90. Portola Pharmaceuticals Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Anticoagulation Therapy Product
Table 94. Roche Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Revenue in Anticoagulation Therapy Business (2016-2021) & (US$ Million)
Table 99. Abbott Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulation Therapy Market Share by Type: 2020 VS 2027
Figure 2. NOACs Features
Figure 3. Warfarin Features
Figure 4. Global Anticoagulation Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hospital Associated Clinics Case Studies
Figure 6. Independent Clinics Case Studies
Figure 7. Pharmacy-Based Clinics Case Studies
Figure 8. Anticoagulation Therapy Report Years Considered
Figure 9. Global Anticoagulation Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Anticoagulation Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anticoagulation Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Anticoagulation Therapy Market Share by Regions (2022-2027)
Figure 13. Global Anticoagulation Therapy Market Share by Players in 2020
Figure 14. Global Top Anticoagulation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulation Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Anticoagulation Therapy Revenue in 2020
Figure 16. Global Anticoagulation Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Anticoagulation Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Anticoagulation Therapy Market Share by Type (2016-2027)
Figure 20. North America Anticoagulation Therapy Market Share by Application (2016-2027)
Figure 21. North America Anticoagulation Therapy Market Share by Country (2016-2027)
Figure 22. United States Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anticoagulation Therapy Market Share by Type (2016-2027)
Figure 26. Europe Anticoagulation Therapy Market Share by Application (2016-2027)
Figure 27. Europe Anticoagulation Therapy Market Share by Country (2016-2027)
Figure 28. Germany Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anticoagulation Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Anticoagulation Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Anticoagulation Therapy Market Share by Region (2016-2027)
Figure 38. China Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anticoagulation Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Anticoagulation Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Anticoagulation Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anticoagulation Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Anticoagulation Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Anticoagulation Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Anticoagulation Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. CH Boehringer Sohn Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 59. Johnson＆Johnson Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 61. Daiichi Sankyo Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 62. Portola Pharmaceuticals Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Anticoagulation Therapy Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の抗凝固療法市場規模・現状・予測（2021年-2027年） Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for…- 世界のホルモンペレット療法市場規模・現状・予測（2021年-2027年） Hormone Pellet Therapy is a method using man-made hormones to replace hormones produced by human body. Market Analysis and Insights: Global Hormone Pellet Therapy Market The global Hormone Pellet Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR…
- 世界の外来用点滴療法サービス市場規模・現状・予測（2021年-2027年） Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health ca…
- 世界の免疫細胞療法市場規模・現状・予測（2021年-2027年） Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy. Market Ana…
- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery Market Analysis and Insights: Global Drugs B…